Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Rome foundation Asian working team report: Real world treatment experience of Asian patients with functional bowel disorders

Authors
Xiong, LishouGong, XiaorongSiah, Kewin Tien-HoPratap, NiteshGhoshal, Uday ChandAbdullah, MurdaniSyam, Ari FahrialBak, Young-TaeChoi, Myung-gyuLu, Ching-LiangGonlachanvit, SutepChua, Andrew Seng BoonChong, Kuck-MengRicaforte-Campos, Jane D.Shi, QuanHou, XiaohuaWhitehead, William E.Gwee, Kok-AnnChen, Minhu
Issue Date
8월-2017
Publisher
WILEY
Keywords
Asia; constipation; functional GI disorders; irritable bowel; treatment
Citation
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, v.32, no.8, pp.1450 - 1456
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume
32
Number
8
Start Page
1450
End Page
1456
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/82692
DOI
10.1111/jgh.13730
ISSN
0815-9319
Abstract
Background and Aim: Information on real world treatment experiences of patients with functional bowel disorders is lacking from Asia. This study aimed to describe the medication exposure and treatment satisfaction of patients presenting to gastroenterology clinics across a sampling of Asian cities. Methods: From March 2011 to October 2013, adult patients presenting to hospital-based gastroenterology outpatient clinics in 11 cities across Asia, who fulfilled screening criteria for any functional gastrointestinal disorder, were asked to complete a validated culturally adapted translation of the Rome III diagnostic questionnaire, a checklist of medications received in the preceding 3 months and questions on treatment satisfaction. Results: A total of 1376 patients (female 755, male 621, 41.36 +/- 13.25 years) comprising irritable bowel (621, 45.1%), unspecified functional bowel disorder (372, 27.8%), functional constipation (202, 14.7%), functional bloating (144, 10.5%), and functional diarrhea (56, 4.1%) completed the study. Of 1105 patients with a previous consultation, 509 (46.1%) were dissatisfied with their treatment, with ineffective treatment being the commonest reason. Satisfaction with previous consultation was lowest by diagnosis for functional constipation (29.2%), and the most bothersome symptom was straining (37.5%). Of 1046 patients who had taken medications for their gastrointestinal symptoms in the last 3 months, 793 (75.8%) had received two or more drugs. For irritable bowel syndrome patients, treatment with proton pump inhibitors and antispasmodics was recorded in 57% and 31%, with overlapping epigastric pain and heartburn predicting proton pump inhibitors use. Conclusions: More attention should be given to treatment gaps with regards to possible under-treatment with antispasmodics in irritable bowel syndrome and to critically evaluating the efficacy of constipation management.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE